SPRINGFIELD — To raise awareness about the importance of cardiovascular health, particularly among minority communities, State Senator Mattie Hunter passed a resolution declaring April 2024 as Minority Health Month in Illinois.

“Heart disease is the leading cause of death among minority populations. We need to empower individuals with the knowledge and resources to best manage their health,” said Hunter (D-Chicago). “By taking a proactive approach, we not only promote healthier lives but can alleviate strain on our health care system.”

Senate Resolution 738 urges Illinoisans to learn more about risk factors for cardiovascular disease, particularly low-density lipoprotein cholesterol levels — commonly referred to as “bad cholesterol” — which can be significantly influenced by an individual’s health habits. The measure also urges the Illinois Department of Public Health to update the state’s cardiovascular plan to accelerate improvements for better health outcomes among individuals with cardiovascular disease and calls for increased cholesterol tests during April.

SPRINGFIELD — Individuals with asthma could see significant savings on their prescription inhalers thanks to legislation from State Senator Mattie Hunter that passed the Senate on Thursday.

“No one should struggle to afford their medication while big companies profit,” said Hunter (D-Chicago). “While insurance plans cover a portion of asthma treatment costs, we can do more to eliminate the barriers individuals face when trying to manage this long-term condition.”

Senate Bill 3203 limits the cost an individual with health insurance pays for an inhaler to $25 for a 30-day supply. Under Hunter’s measure, health insurance providers would be prohibited from denying or limiting coverage for prescription inhalers beginning Jan. 1, 2026.

According to Illinois Department of Public Health data from 2018, more than 850,000 adults and 160,000 children in the state are diagnosed with asthma. Despite insurance coverage, many individuals still face out-of-pocket expenses ranging from $180 to $300 per month for inhalers. This legislation aims to alleviate this financial burden on asthma patients.

“In Illinois, we continue to prioritize residents’ needs by tackling rising medical costs, including limiting the price of EpiPens and insulin,” said Hunter. “This is one more step toward making health care affordable and accessible to those who need it.”

Senate Bill 3203 moves to the House for further consideration.

SPRINGFIELD — By 2050, global demand for meat is expected to rise by 50%, and meeting this demand with conventional protein options alone would accelerate pollution and drain limited resources. To proactively explore Illinois’ sustainable protein options, State Senator Mattie Hunter has been appointed co-chair of the Illinois Alternative Protein Innovation Task Force.

“After advancing legislation to create the Alternative Protein Innovation Task Force, I value the opportunity to join in on this valuable work,” said Hunter (D-Chicago). “This unique opportunity allows us to explore groundbreaking solutions to concerns in the agriculture sector that align with our commitment to sustainability and economic growth.”

The task force is set up to explore different protein sources and assess their potential benefits, with the ultimate goal of understanding how alternative proteins — like plant-based protein, cultivated meat and fermented proteins — could boost the economy, create jobs and reduce the environmental impacts of traditional meat production.

SPRINGFIELD — To help alleviate the financial burden on individuals with asthma, State Senator Mattie Hunter is leading a measure to limit the out-of-pocket costs for prescription inhalers.

“As someone with asthma, I know how expensive it is to get the medicine I need to breathe,” said Hunter (D-Chicago). “For families needing multiple inhalers a month, the costs quickly add up, forcing some to choose between their medication and other necessities.”

Senate Bill 3203 limits the cost an individual with health insurance pays for an inhaler to $25 for a 30-day supply. Under Hunter’s measure, health insurance providers would be prohibited from denying or limiting coverage for prescription inhalers beginning Jan. 1, 2026.